The novel therapy of this peptide represents a significant breakthrough in the handling of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide affects two pathways – GLP-1 and GIP – providing https://tirzepatidepeptide200166.glifeblog.com/40606048/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment